Prestige Consumer Healthcare Inc. (NYSE:PBH) Stock Holdings Reduced by Victory Capital Management Inc.

Victory Capital Management Inc. reduced its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 1.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 674,402 shares of the company’s stock after selling 9,362 shares during the period. Victory Capital Management Inc.’s holdings in Prestige Consumer Healthcare were worth $41,287,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Ariel Investments LLC grew its stake in shares of Prestige Consumer Healthcare by 173.8% in the 3rd quarter. Ariel Investments LLC now owns 2,534,786 shares of the company’s stock valued at $144,964,000 after buying an additional 1,609,044 shares in the last quarter. Massachusetts Financial Services Co. MA grew its position in Prestige Consumer Healthcare by 0.8% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,101,504 shares of the company’s stock worth $62,995,000 after acquiring an additional 8,661 shares in the last quarter. Allspring Global Investments Holdings LLC increased its stake in shares of Prestige Consumer Healthcare by 19.1% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,087,821 shares of the company’s stock worth $62,213,000 after purchasing an additional 174,416 shares during the last quarter. Northern Trust Corp raised its holdings in shares of Prestige Consumer Healthcare by 3.9% during the 3rd quarter. Northern Trust Corp now owns 724,358 shares of the company’s stock valued at $41,426,000 after purchasing an additional 27,287 shares in the last quarter. Finally, Jennison Associates LLC lifted its stake in shares of Prestige Consumer Healthcare by 3.0% in the 3rd quarter. Jennison Associates LLC now owns 477,821 shares of the company’s stock valued at $27,327,000 after purchasing an additional 13,871 shares during the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Stock Performance

NYSE PBH opened at $70.00 on Monday. The stock has a 50-day simple moving average of $71.12 and a 200 day simple moving average of $64.66. Prestige Consumer Healthcare Inc. has a twelve month low of $55.96 and a twelve month high of $75.31. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.09 and a quick ratio of 1.92.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, February 8th. The company reported $1.06 EPS for the quarter, topping the consensus estimate of $1.04 by $0.02. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. The company had revenue of $282.74 million for the quarter, compared to the consensus estimate of $280.25 million. During the same period in the previous year, the business posted $1.04 EPS. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. On average, research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.33 EPS for the current fiscal year.

Insider Activity at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 5,336 shares of the firm’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $69.00, for a total value of $368,184.00. Following the sale, the senior vice president now directly owns 15,934 shares in the company, valued at approximately $1,099,446. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on the stock. TheStreet raised shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research report on Monday, February 12th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, February 10th. One equities research analyst has rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $110.00.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.